ADVFN Logo
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

NWBO Northwest Biotherapeutics Inc (QB)

0.548
0.0079 (1.46%)
Feb 29 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 1,224,236
Bid Price 0.545
Ask Price 0.548
News -
Day High 0.56575

Low
0.4001

52 Week Range

High
1.11

Day Low 0.5401
Company Name Stock Ticker Symbol Market Type
Northwest Biotherapeutics Inc (QB) NWBO OTCMarkets Common Stock
  Price Change Change Percent Stock Price Last Traded
0.0079 1.46% 0.548 16:15:30
Open Price Low Price High Price Close Price Prev Close
0.545 0.5401 0.56575 0.5401
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
380 1,224,236 $ 0.547576 $ 670,362 - 0.4001 - 1.11
Last Trade Time Type Quantity Stock Price Currency
15:59:33 3,000 $ 0.548 USD

Northwest Biotherapeutics Inc (QB) Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
196.15M 1.10B 972.39M 1.68M -105.03M -0.09 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Northwest Biotherapeutics (QB) News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No NWBO Message Board. Create One! See More Posts on NWBO Message Board See More Message Board Posts

Historical NWBO Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.590.600.5320.54655361,913,352-0.042-7.12%
1 Month0.5430.650.530.56625411,802,9880.0050.92%
3 Months0.760.860.530.63278041,784,871-0.212-27.89%
6 Months0.5251.110.490.73446662,168,3060.0234.38%
1 Year0.69991.110.40010.66739181,879,857-0.1519-21.70%
3 Years1.442.150.38620.89900612,106,887-0.892-61.94%
5 Years0.2492.540.0050.84802182,286,8740.299120.08%

Northwest Biotherapeutics (QB) Description

Northwest Biotherapeutics, Inc. is a development stage biotechnology company focused on discovering, developing and commercializing immunotherapy products that generate and enhance immune system responses to treat cancer. The Company operates in the United States, the UK, Germany and Canada and is incorporated in Delaware, USA.

Your Recent History

Delayed Upgrade Clock